J. Edlmayr

Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases.

R. Valenta, K. Niespodziana, B. Linhart, 2011, Current topics in microbiology and immunology.

Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin

D. Blaas, R. Valenta, B. Pfanzagl, 2013, Archives of Virology.

Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation

R. Valenta, T. Popow-Kraupp, D. Blaas, 2010, European Respiratory Journal.

A Combination Vaccine for Allergy and Rhinovirus Infections Based on Rhinovirus-Derived Surface Protein VP1 and a Nonallergenic Peptide of the Major Timothy Grass Pollen Allergen Phl p 11

R. Valenta, T. Popow-Kraupp, P. Valent, 2009, The Journal of Immunology.

Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin

D. Blaas, R. Valenta, B. Pfanzagl, 2013, Archives of Virology.